Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Healthcare Medical Devices
Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > The BEST automation and analysis on the PLANET GEN3EHO
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1167)
•••
Comment by Pandoraon Sep 25, 2024 3:24pm
71 Views
Post# 36240833

RE:RE:RE: Re: The BEST automation and analysis on the PLANET GEN3EHO

RE:RE:RE: Re: The BEST automation and analysis on the PLANET GEN3EHO
Another article by Ascend on the benefits of GEN3ECHO. We have established that the GEN3ECHO resume includes a description of Ventripoint.

We certainly have all kinds of news items being put out re Ventripoint and VMS 3+ and VMS 4.

The one thing that continues to bother me is that they seem to always ignore any remark or discussion re sales. I believe a discussion on sales, or the lack thereof, is the single biggest factor keeping us as a two bit stock.

Whenever management decides to put out news in one form or another to discuss sales I totally believe we will see a significant change in the price level. IMHO!
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities